Reva touts first implant of Fantom Encore bioresorbable scaffold in Switzerland

Reva Medical (ASX:RVA) announced today that the company’s Fantom Encore bioresorbable vascular scaffold was used for the first time in Switzerland.
The sirolimus-eluting device, which is made from Reva’s proprietary Tyrocore polymer, features a 95-micron strut profile and x-ray visibility.
Get the full story at our sister site, Drug Delivery Business News.
The post Reva touts first implant of Fantom Encore bioresorbable scaffold in Switzerland appeared first on MassDevice.

Source: Mass Device - March 28, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Implants Pharmaceuticals Vascular Wall Street Beat Reva Medical Inc. Source Type: news